Profile: Shanghai SynCores Technologies, Inc. is a chemistry synthesis service provider. We develop novel drug intermediates, drug-like scaffolds and building blocks to meet the needs of global pharmaceutical & biopharmaceutical companies. Our products include kinase scaffolds, heterocyclic amine, heterocyclic acid and pharmaceutical intermediates. Our kinase scaffolds include 4,6-dichloro-1H-pyrazolo[3,4-d]pyrimidine, 6-bromo-2-chloroquinoline, 2-bromo-4-chlorothieno[3,2-c]pyridine, 7-bromo-4-chlorothieno[3,2-d]pyrimidine, 5,7-dichloropyrazolo[1,5-a]pyrimidine, 4-chlorothieno[3,2-d]pyrimidine, 6-bromo-4-chlorothieno[2,3-d]pyrimidine and 7-chlorothieno[3,2-b]pyridine. Our pharmaceutical intermediates are 4-(2-hydroxyethyl)indolin-2-one, 4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine, (S)-3-(dimethylamino)-1-(thiophen-2-yl)propan-1-ol and (S)-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine. We also offer various heterocyclic acids such as 4-chloroquinazoline-7-carboxylic acid, 4-chloroquinoline-6-carboxylic acid, 7-chloroquinoline-3-carboxylic acid, 4-bromoquinoline-6-carboxylic acid, 6-bromoquinazoline-4-carboxylic acid, 2-chloroquinoline-4-carboxylic acid, 8-chloroquinoline-3-carboxylic acid and 4-chloroquinoline-7-carboxylic acid. We offer molecule synthesis, scale up and process research & development. We provide project-based synthesis services including lead optimization, process chemistry development, and synthesis of key & advanced intermediates, reference compounds & small focused libraries. We render novel scaffolds and building blocks to answer the increasing demand for novel, drug-like molecules for use in early drug discovery.